ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
陸道培醫療集團(臨時代碼)
成交量:
- -
成交額:
- -
市值:
- -
市盈率:
- -
高:
- -
開:
- -
低:
- -
收:
- -
52周最高:
- -
52周最低:
- -
股本:
- -
香港流通股本:
- -
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
市銷率:
- -
資料載入中...
總覽
公司
新聞資訊
公告
6年估值漲20倍,陸道培醫療究竟值不值?
公司研究室
·
2023/02/02
一圖解碼:陸道培醫療IPO 虧損近十億 血液病賽道很燒錢?
财华社
·
2023/01/06
陸道培醫療集團衝港股,淡馬錫入股,兩年九個月虧10億元
浙江新闻
·
2023/01/05
新股前瞻|陸道培:血液病醫療服務市場供需缺口大 「流血」擴張仍需警惕
金融界网站
·
2023/01/04
新股前瞻|陸道培:血液病醫療服務市場供需缺口大 「流血」擴張仍需警惕
智通财经网
·
2023/01/04
國內最大血液病醫院陸道培醫療集團遞表,近三年累計虧超10億元
财联社
·
2023/01/04
【新股消息 | 陸道培醫療遞表港交所 為中國最大的血液病醫療服務提供商】智通財經APP獲悉,據港交所2022年1月3日披
智通财经
·
2023/01/04
新股消息 | 陸道培醫療遞表港交所 為中國最大的血液病醫療服務提供商
智通财经
·
2023/01/04
【新股IPO】陸道培醫療集團向港交所遞交上市申請 為中國最大的血液病醫療服務提供商
凤凰网港股
·
2023/01/03
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/90119/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"90119","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90119\",,,,,undefined,":{"symbol":"90119","market":"HK","secType":"STK","nameCN":"陸道培醫療集團(臨時代碼)","latestPrice":0,"timestamp":1774339200000,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":0,"latestTime":"03-24 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774402200000},"marketStatusCode":5,"adr":0,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1774315800000,1774324800000],[1774328400000,1774339200000]],"volumeRatio":0,"lotSize":0,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90119\",,,,,undefined,":{"symbol":"90119","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/90119\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"90119\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"90119\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"90119\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2308209046","title":"6年估值漲20倍,陸道培醫療究竟值不值?","url":"https://stock-news.laohu8.com/highlight/detail?id=2308209046","media":"公司研究室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2308209046?lang=zh_tw&edition=fundamental","pubTime":"2023-02-02 12:31","pubTimestamp":1675312260,"startTime":"0","endTime":"0","summary":"虽然近年来迅速扩大规模,但陆道培医疗至今却并未真正实现盈利。究其原因,毛利率过低是陆道培医疗亏损的主要因素之一。河北燕达陆道培医院2015年投入运营,贡献了陆道培医疗70%的业绩。2022年前三季度,燕达陆道培医院创造了8.27亿元的收入,毛利率由截至2021年9月30日止九个月的21.5%增加至2022年同期的23.4%。截至2022年9月30日,公司已租赁医院场地并产生资本支出4280万元。短期内无法盈利的现实,更增加了陆道培医疗","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzIwNjM4MjI4Mg==&mid=2247488542&idx=1&sn=89ffb6d20f6b0d9f20a6a985d5a7ed16&chksm=972321bba054a8ad0ed8793ec3b7409bb7ed23179b7de583103a5c42c36536cd54304b017755#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["90119"],"gpt_icon":0},{"id":"2301190362","title":"一圖解碼:陸道培醫療IPO 虧損近十億 血液病賽道很燒錢?","url":"https://stock-news.laohu8.com/highlight/detail?id=2301190362","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2301190362?lang=zh_tw&edition=fundamental","pubTime":"2023-01-06 10:48","pubTimestamp":1672973281,"startTime":"0","endTime":"0","summary":"1月3日,陆道培医疗向港交所递交了招股书,计划在主板挂牌上市;由中信证券、招银国际和麦格理担任联席保荐人。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202301_1/3e99e188-e13f-431c-9c99-9be9e73723e6.jpg","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202301_1/3e99e188-e13f-431c-9c99-9be9e73723e6.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/63b78be153243c0e604c4041","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["90119"],"gpt_icon":0},{"id":"2301803258","title":"陸道培醫療集團衝港股,淡馬錫入股,兩年九個月虧10億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2301803258","media":"浙江新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2301803258?lang=zh_tw&edition=fundamental","pubTime":"2023-01-05 18:58","pubTimestamp":1672916334,"startTime":"0","endTime":"0","summary":"近日,陆道培医疗集团(以下简称“陆道培医疗”)向港交所递交招股书,申请在港股上市,联席保荐人为中信证券、招银国际及麦格理。据悉,陆道培医疗由开创中国血液病治疗先河并奠定血液病医 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20230105/c644077440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["90119","159891"],"gpt_icon":0},{"id":"2301059544","title":"新股前瞻|陸道培:血液病醫療服務市場供需缺口大 「流血」擴張仍需警惕","url":"https://stock-news.laohu8.com/highlight/detail?id=2301059544","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2301059544?lang=zh_tw&edition=fundamental","pubTime":"2023-01-04 19:33","pubTimestamp":1672831982,"startTime":"0","endTime":"0","summary":"巨大的未满足的医疗需求加上不断增长的患者基础预计将推动中国血液病医疗服务市场增长。预计医院扩张将成为陆道培未来在血液病医疗服务市场实现增长的基石。 陆道培医疗的盈利能力有所下滑,毛利率整体呈现下降态势。 陆道培“流血”扩张的原因,与血液病市场庞大的供需缺口有关。截至2021年,中国约有2170万患者确诊血液系统疾病,其中约有21万例为血液肿瘤新发病例。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2023/01/04193337259347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["90119"],"gpt_icon":0},{"id":"2300282084","title":"新股前瞻|陸道培:血液病醫療服務市場供需缺口大 「流血」擴張仍需警惕","url":"https://stock-news.laohu8.com/highlight/detail?id=2300282084","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2300282084?lang=zh_tw&edition=fundamental","pubTime":"2023-01-04 19:33","pubTimestamp":1672831982,"startTime":"0","endTime":"0","summary":"亏损持续扩大的同时,陆道培选择了继续扩张。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20230104/20230104193441_81776.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20230104/20230104193441_81776.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/857225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["90119"],"gpt_icon":0},{"id":"1154063162","title":"國內最大血液病醫院陸道培醫療集團遞表,近三年累計虧超10億元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154063162","media":"财联社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154063162?lang=zh_tw&edition=fundamental","pubTime":"2023-01-04 18:28","pubTimestamp":1672828131,"startTime":"0","endTime":"0","summary":"陆道培医疗集团向港交所主板提交上市申请。","market":"hk","thumbnail":"https://static.tigerbbs.com/6098c6e789f5cc0074835cd59796a21d","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6098c6e789f5cc0074835cd59796a21d"],"rights":{"source":"cailianpress","url":"https://www.cls.cn/detail/1230171","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cls.cn/detail/1230171","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cailianpress","symbols":["159718","90119"],"gpt_icon":0},{"id":"2300849272","title":"【新股消息 | 陸道培醫療遞表港交所 為中國最大的血液病醫療服務提供商】智通財經APP獲悉,據港交所2022年1月3日披","url":"https://stock-news.laohu8.com/highlight/detail?id=2300849272","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2300849272?lang=zh_tw&edition=fundamental","pubTime":"2023-01-04 09:30","pubTimestamp":1672795858,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1516","BK0183","LU1997245177.USD","BK0028","BK0188","BK0012","BK1564","600030","LU1720050803.USD","BK0276","LU1794554557.SGD","LU1997245094.SGD","BK0196","BK1147","06030","BK1521","90119","159891"],"gpt_icon":0},{"id":"2300492203","title":"新股消息 | 陸道培醫療遞表港交所 為中國最大的血液病醫療服務提供商","url":"https://stock-news.laohu8.com/highlight/detail?id=2300492203","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2300492203?lang=zh_tw&edition=fundamental","pubTime":"2023-01-04 09:30","pubTimestamp":1672795858,"startTime":"0","endTime":"0","summary":"陆道培招股书显示,根据弗若斯特沙利文的资料,就2021年的收入以及截至2021年12月31日血液病患者的登记床位数量及造血干细胞移植仓位数而言,公司是中国最大的血液病医疗服务提供商。于往绩记录期间,河北燕达陆道培医院于2017年1月被认定为医疗保险定点医疗机构并为公司总收入贡献绝大一部分。北京陆道培医院亦庄院区及北京陆道培医院顺义院区分别于2021年1月和2020年12月被认定为医疗保险定点医疗机构,并因此经历了快速的业务增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/856744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["90119","159891"],"gpt_icon":0},{"id":"2300618450","title":"【新股IPO】陸道培醫療集團向港交所遞交上市申請 為中國最大的血液病醫療服務提供商","url":"https://stock-news.laohu8.com/highlight/detail?id=2300618450","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2300618450?lang=zh_tw&edition=fundamental","pubTime":"2023-01-03 23:20","pubTimestamp":1672759220,"startTime":"0","endTime":"0","summary":"据港交所1月3日文件:陆道培医疗集团向港交所递交上市申请,中信证券、招银国际和麦格理为联席保荐人。根据弗若斯特沙利文的资料,按2021年的造血干细胞移植病例数计算,公司于中国排名第二,且在中国的造血干细胞移植服务市场中,公司在2021年进行的异基因造血干细胞移植数量排名第一,进行的半相合造血干细胞移植数量排名第二。就2021年血液病特检服务产生的收入而言,公司还是该项服务的中国第三大提供商。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=fbc886d3f7d0f3086ad4c0f84008727c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["90119","159891","IPO"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}